NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485 in Subjects With Early Untreated Parkinson's Disease A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485in Subjects With Early Untreated Park ...
Parkinson Disease
Drug: CoQ10;Drug: GPI 1485
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS)
2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD 2 Year Study to Evaluate the Effects of GPI 1485on [123I]b-CIT/SPECTScanning and Clinical Efficacy i ...
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects Of GPI 1485 On [123I]b-CIT/SPECT Scanning And Clinical Efficacy In Symptomatic PD Patients Receiving Dopamine Agonist Therapy. Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects O ...